Evonik plunges after BASF drops takeover over

Evonik shares fell 17% after BASF withdrew its takeover attempt. BASF had made two all-cash offers, both rejected by Evonik. BASF's stock rose 2.9%.

Original reporting
Published Nov 19, 2026, 3:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 19, 2026, 3:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Evonik plunges after BASF drops takeover over — source image
Decision brief

The 30-second read

$EVKIFBearishMed
01

Why it matters

The immediate market reaction suggests investors were pricing a deal premium for Evonik. BASF’s rise implies the market viewed the termination as reducing acquisition risk or cost.

02

Market read

Deal abandonment is a direct repricing event for both companies, especially for Evonik where takeover probability collapses.

03

What to watch

The article does not state whether BASF will pursue alternative structures (smaller stake, different price, or different assets), which could change the medium-term outlook.

Relevance 7/10Novelty 6/10Timing: in German trading today, immediately after BASF ended the takeover effort

Background

BASF pursued an all-cash takeover of Evonik via two non-binding offers; Evonik rejected them, and BASF then dropped the effort.

Company-level read

Ticker impact

$EVKIFBearishHigh confidence
Context

Evonik shares plunged about 17% in German trading after BASF dropped its takeover efforts following Evonik’s rejection of two offers.

Expected impact

Likely further downside or volatility as the market reprices the probability of a deal and the lost premium.

Evidence & confidence

The article attributes the sharp selloff directly to BASF abandoning the purchase after Evonik rejected non-binding offers, a clear negative catalyst.

Market effects

Signals shifting M&A appetite in chemicals, potentially affecting deal expectations and valuation multiples for other specialty chemical targets.

May influence sentiment across German and broader European chemicals names tied to takeover speculation.

Could modestly affect cross-border chemicals M&A pricing and the perceived likelihood of future all-cash bids.

Counterpoint

Evonik’s rejection of non-binding offers could still leave room for future negotiations, so the selloff may be partially overdone if a revised bid emerges.

Key entities

  • Evonik

    Chemicals company whose takeover talks with BASF ended, triggering a sharp selloff.

  • BASF

    Chemicals company that abandoned its takeover efforts after Evonik rejected non-binding offers.

Related articles

$BAS.DEMed

Evonik shares rise on report BASF prepares renewed takeover offer

BASF (BASFn) is reportedly preparing a renewed takeover offer for Evonik (EVKn) after an earlier €11 billion bid was rejected. BASF is seeking input from German lawmakers and stakeholders to address regulatory and political concerns. Evonik's shares rose 3.3%, while BASF's fell 2.2% on the news. According to Bloomberg, BASF is offering structural guarantees to secure support for the deal.